Get the Stockscreener App
0.442
8.15%
-0.0392
After Hours:
.39
-0.052
-11.76%
Nexalin Technology Inc stock is traded at $0.442, with a volume of 153.23K.
It is down -8.15% in the last 24 hours and up +24.51% over the past month.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
See More
Previous Close:
$0.4812
Open:
$0.4954
24h Volume:
153.23K
Relative Volume:
0.28
Market Cap:
$9.73M
Revenue:
$275.60K
Net Income/Loss:
$-8.33M
P/E Ratio:
-0.9569
EPS:
-0.4619
Net Cash Flow:
$-5.40M
1W Performance:
-10.03%
1M Performance:
+24.51%
6M Performance:
-25.27%
1Y Performance:
-61.90%
1-Day Range:
$0.439
$0.4954
1-Week Range:
$0.439
$0.5099
52-Week Range:
$0.305
$2.00
Nexalin Technology Inc Stock (NXL) Company Profile
Name
Nexalin Technology Inc
Sector
Industry
Phone
(832) 260-0222
Address
1776 YORKTOWN, HOUSTON
Compare NXL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
0.442 | 10.59M | 275.60K | -8.33M | -5.40M | -0.4619 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nexalin Technology Inc Stock (NXL) Latest News
Nexalin Appeals Nasdaq Delisting Following Compliance Shortfalls - TipRanks
Nexalin Technology Received Notice of Delisting - TradingView
NXL|Nexalin Technology Inc|Price:0.483|Chg%:+0.002 - TradingKey
Nexalin Technology Inc (NXL) Cash Flow - TradingKey
Nexalin Technology Inc (NXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NXL|Nexalin Technology Inc|Price:0.500|Chg%:+0.019 - TradingKey
Nexalin Technology Inc (NXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nexalin Technology Inc (NXL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nexalin Technology Inc (NXL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
NXL|Nexalin Technology Inc|Price:0.481|Chg%:+0.013 - TradingKey
Nexalin Technology, Inc. Revenue Breakdown – NASDAQ:NXL - TradingView
Nexalin Technology Inc (NXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nexalin Technology (NXL) Registration filing Summary - Quartr
Nexalin Technology Inc. (NXL) Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Development StageProfitability Analysis - dars.gov.et
Nexalin Technology (NXL) Surges Over 11% as Shares Test Key Resistance LevelATR Stop - dars.gov.et
NXL | Nexalin Technology, Inc. Common Executive Compensation - Quiver Quantitative
Nexalin Technology | ARS: Annual Report to Security Holders - Moomoo
Form DEF 14A Nexalin Technology Inc For: 10 July By Investing.com - Investing.com Nigeria
Nexalin Technology (NXL) plans new 7M-share incentive pool and reverse split authority - Stock Titan
Nexalin Technology (NXL) Proxy filing Summary - Quartr
Nexalin Technology (NXL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage ContinuesFinal Results - DonanımHaber
Enterprise value to revenue forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
Price to book forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
Price to sales forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
Price to earnings forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
NXL Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 5%Margin Compression Risk - dars.gov.et
Form PRE 14A Nexalin Technology Inc For: 29 June By Investing.com - Investing.com South Africa
Nexalin Technology (NXL) seeks shareholder votes for equity plan, reverse split - Stock Titan
NexaLine Technology Registers 1.2 Million Shares for Resale - Moomoo
Nexalin Technology | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
Nexalin Technology Secures US Patent for Deep-Brain Stimulation Targeting Insomnia - Sleep Review
Nexalin Technology Inc. (NXL) Q1 2026 Earnings: EPS Miss Amid Pre-Revenue Stage, Stock Rises 4%Profit Guidance Range - dars.gov.et
Nexalin Technology, Inc. Actuals & Estimates (NASDAQ:NXL) - TradingView
$Nexalin Technology (NXL.US)$ - Moomoo
Nexalin Technology Inc (NXLIW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NXL Forecast — Price Target — Prediction for 2027 - TradingView
Nexalin Technology Inc (NXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NXL Stock Price, Quote & Chart - ChartMill
Nexalin Technology Announces that the Investigator of Its - GlobeNewswire
Exclusive: Nexalin Brazil trial shows benefits across anxiety, sleep and quality of life - MSN
Nexalin Technology (NXL) Continues Slide, Approaches Critical Support at $0.35Volume Weighted Price - DonanımHaber
Nexalin Technology, Inc. Financial Disclosures & SEC Filings - TradingView
NXL Q1 2026 Earnings: Wider-than-Expected Loss Pressures SharesShare Repurchase Impact - dars.gov.et
Nexalin Technology Inc (NXL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nexalin Technology Inc (NXL) Institutional Confidence - TradingKey
Nexalin Technology Inc (NXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nexalin Technology Inc (NXLIW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nexalin Technology Inc (NXLIW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nexalin Technology Inc (NXLIW) Institutional Confidence - TradingKey
Nexalin Technology Inc (NXLIW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nexalin Technology Adopts Second Amended and Restated Bylaws Effective June 16, 2026 - Minichart
Nexalin Technology Inc Stock (NXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):